Kindstar Globalgene Technology, Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 659.48 million compared to CNY 438.2 million a year ago. Net income was CNY 62.54 million compared to net loss of CNY 1,501.7 million a year ago.

Basic earnings per share from continuing operations was CNY 0.07 compared to basic loss per share from continuing operations of CNY 10.33 a year ago. Diluted earnings per share from continuing operations was CNY 0.06 compared to diluted loss per share from continuing operations of CNY 10.33 a year ago.